AzTrials
AzTrials

HivNCT03571555

Prospective Cohort Study of Adolescents Living With HIV and Their Caregivers Attending a Psychosocial Programme in Botswana

An observational study of Hiv, run by Royal Holloway University at 1 site in Botswana.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Adolescents/young adults with perinatally acquired HIV (PAH) face a number of antiretroviral (ART) adherence and well-being challenges. Two psychosocial interventions that have been developed to address a range of needs of this population (and their caregivers) are residential interventions (camps) and support groups… Read more about this study

Who is it for?
Ages 10 to 19 years
Conditions the study is for
Hiv
What is being tested?
Sentebale Psychosocial Programme
How many people
516 participants
Where
1 siteBotswana
Study dates
1 Mar 2019to 1 Jul 2020
Phase
Observational
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 19 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: 10-19 year olds living with HIV, new attenders to the Sentebale psychosocial programme Primary caregivers of 10-19 year olds living with HIV attending Sentebale, who are also attending Sentebale themselves

Who may be able to join

  • Aged 10 to 19 years at the time of study enrolment
  • Living with HIV and aware of HIV-positive status
  • Able to give informed consent if 18 or 19 years
  • Able to give informed assent if 10-17 years
  • Presence of a caregiver to give caregiver consent if 10-17 years
  • Attending Sentebale clubs with first attendance at club within previous month
Show all 9Show fewer
  • Primary caregiver for a young person attending Sentebale
  • Able to give informed consent
  • Attending Sentebale clubs with first attendance within previous month

Who cannot join

  • Previous camp attendance
  • Any attendance at a different club/organisation providing a similar function
  • Planning to leave the area served by the club within the next year
  • CAREGIVERS
  • Any attendance at a different club/organisation providing a similar function
  • Planning to leave the area served by the club within the next year

Trial locations and contacts

1 site in 1 country.

Botswana1 site
  • Sentebale

    Gaborone

Other trials in Botswana

About this study

Official title: A Prospective Cohort Study Evaluating a Psychosocial Programme for Adolescents Living With HIV and Their Caregivers in Botswana

Adolescents/young adults with perinatally acquired HIV (PAH) face a number of antiretroviral (ART) adherence and well-being challenges. Two psychosocial interventions that have been developed to address a range of needs of this population (and their caregivers) are residential interventions (camps) and support groups (clubs). There has been little quantitative evaluation of the effects of attending camps for young people and clubs (for children or caregivers), globally. This study aims to investigate whether a package of psychosocial support (camps and clubs) offered to young people living with HIV and their caregivers in Botswana by the Sentebale organisation, is associated with improvements in psychological, behavioural and clinical outcomes from first attendance to one year follow-up. In addition, the study will explore how the psychosocial programme is experienced by young people and their caregivers, and what the perceived impact is. The project as a whole will take place over three years. There will be an initial six month preparatory phase that will include the adaptation of self-report measures for the study context. Subsequently, two studies will be undertaken. The main study will involve a single group within-participants prospective cohort design with two time points (baseline and one year follow-up) with young people and caregivers. The sub-study will involve a qualitative cross sectional design involving semi-structured interviews with young people and caregivers. Young people will be eligible to participate if they are aged 10 to 19 years at the time of study enrolment, are living with HIV and aware of HIV-positive status, have recently started attending the Sentebale programme, and are able to give informed assent/consent. We will aim to retain 175 young people (of 253 recruited) . We will also aim to retain 178 caregivers (of 263 recruited). The sample size for the sub-study will consist of ten young people and ten caregivers.

Read the detailed description

There are approximately two million young people between 10 and 19 years, living with HIV (UNAIDS, 2013). Many of this population have been living with HIV since birth. Adolescents/young adults with perinatally acquired HIV (PAH) face a number of antiretroviral (ART) adherence and well-being challenges. They often have long histories of ART use with suboptimal regimens (Sohn \& Hazra, 2013) and rates of viral suppression are variable, often associated with poor ART adherence (Kim, Gerver, Fidler, \& Ward, 2014). Challenges to positive well-being in young people with PAH include some experiencing multiple caretaking transitions, loss due to parental illness or death, and other stressors associated with living with a chronic and stigmatised illness (e.g., hospitalisations, missed school and social opportunities, HIV disclosure challenges and pain). There is evidence of lower levels of wellbeing in young people living with PAH compared to their HIV unaffected peers (Mellins \& Malee, 2013).

Offering psychosocial interventions for young people living with HIV has the potential for enhancing well-being, HIV adjustment, ART adherence, self-esteem and increasing HIV knowledge and HIV disclosure. There are a small number of quantitative studies evaluating interventions to enhance antiretroviral adherence in young people with HIV (Shaw \& Amico, 2016) but few robust quantitative evaluations of psychosocial interventions to enhance well-being in this population (King, De Silva, Stein, \& Patel, 2009). There are no interventions on enhancing onward HIV disclosure in adolescents living with HIV (Evangeli \& Foster, 2014).

Two psychosocial interventions that have been developed to address a range of needs of this population (and their caregivers) are residential interventions and support groups. Regarding residential interventions, there is quantitative evidence in other chronic conditions of increased youth self-esteem after attendance (Odar, Canter, \& Roberts, 2013). There is also some qualitative literature on evaluating residential interventions (support camps) for young people living with HIV in the US (Gillard \& Allsop, 2016; Gillard, Witt, \& Watts, 2011; Pearson, Johnson, Simpson, \& Gallagher, 1997). Interviews with Camp attendees have revealed that this intervention can elicit a sense of belonging, enjoyment, escape, personal growth, being oneself, and caring connections, as well as increasing HIV knowledge, attitudes and skills. A recent quantitative evaluation of a residential intervention in the UK showed evidence for increases in HIV knowledge and pro-HIV disclosure attitudes and cognitions that were maintained at six month follow-up (Evangeli, Lut, \& Ely, 2016).

There is also some global evidence of positive benefits of support groups for children living with HIV, who report that groups provide a sense of belonging, normality, confidence and safety; supportive relationships; and a place to learn about treatment adherence and living healthily (Brothers, Harper, Fernandez, Hosek, \& Adolescent Trials Network for, 2014; Funck-Brentano et al., 2005; Midtbo, Shirima, Skovdal, \& Daniel, 2012; Mupambireyi, Bernays, Bwakura-Dangarembizi, \& Cowan, 2014; Muskat, Salter, Shindler, Porter, \& Bitnum, 2016). There has been little quantitative evaluation of the effects of attending support groups (for children or caregivers), although one pilot study using non-random allocation, showed some evidence of decreased worry about illness, less negative perception about treatment and greater rates of viral suppression in adolescents living with HIV (Funck-Brentano et al., 2005).

Sentebale is an organisation that has been providing residential interventions (camps) to adolescents living with HIV, and follow up support groups (clubs) for these adolescents and their caregivers, amongst other psychosocial interventions, in Lesotho for a number of years. Sentebale is now offering a similar package of psychosocial services to young people and caregivers in Botswana, partnering with Serious Fun Children's Network. The aims of Sentebale are to provide support that will enable young people to living healthy and hopeful lives, increase confidence, improve educational and occupational functioning, increase care and support, enhance HIV communication, increase caregiver support, reduce onward transmission, and increase remembering to take medication. We will evaluate the above psychosocial programme, given the need to investigate the psychosocial, behavioural and clinical outcomes of this type of intervention in high HIV prevalence contexts. Botswana has an estimated HIV prevalence of 6.6% in 15-19 year olds, and an estimated adult prevalence rate of 18.5%, and despite high levels of ART adherence, psychological difficulties in this population are common (Gupta et al., 2010).

Aims and objectives

This three year study aims to answer the following questions in a population of adolescents living with HIV and their caregivers:

  1. Is the package of support offered by Sentebale (camps for young people, clubs for young people and caregivers) associated with improvements in psychological, behavioural and clinical outcomes from first attendance to one year follow-up?
  2. How is the package of support experienced by young people and their caregivers, and what is the perceived impact for young people and their caregivers?

Study Design

  1. Main study - single group within-participants prospective cohort design with two time points (baseline and one year follow-up) with 175 young people and 178 caregivers retained in the study (Study Aim 1).
  2. Sub-study - qualitative cross sectional design involving semi-structured interviews with 10 young people and 10 caregivers (Study Aim 2).
Conditions
Hiv
Being tested
Sentebale Psychosocial Programme
Keywords
HIV, perinatal, adolescent, camp, psychosocial
Medical subject headings
Acquired Immunodeficiency Syndrome, Muscle Cramp

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sentebale Psychosocial ProgrammeBehavioural

    Residential interventions (camps) for the young people, and community based support (clubs) for the young people and the caregivers.

Study groups in NCT03571555
Study groupRoleWhat they receive
Young people with perinatally acquired HIVResidential interventions (camps) and community based support (clubs)
Receives: Behavioral: Sentebale Psychosocial Programme
Caregivers of young people with perinatally acquired HIVCommunity based support (clubs)
Receives: Behavioral: Sentebale Psychosocial Programme

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of Life/Well-being (Young People)

    The 17 item Pediatric Symptom Checklist (PSY-Y-17) will be used.

    Minimum value 0, maximum 51. Higher scores, worse outcome.

    Measured: One year

Secondary outcomes (18)
  1. HIV Knowledge (Young People)

    The Brief HIV Knowledge Questionnaire (Carey \& Schroder, 2002) and other measures (Aaro et al, 2011; Evangeli et al, 2016) will be adapted to produce a new measure of general HIV knowledge, transmission, medication and reproduction information.

    Measured: One year

  2. HIV Adjustment (Young People)

    The 18 item Illness Cognition Questionnaire will be used (Evers et al., 2001).

    Measured: One year

  3. ART Adherence Behaviour (Young People)

    The total score of the CASE adherence index (Mannheimer et al., 2006) will be used. Higher scores indicate higher self-reported ART adherence

    Measured: One year

  4. ART Adherence Attitudes (Young People)

    The total score of 15 item antiretroviral medication attitudes scale (Viswanathan, Anderson, \& Thomas, 2005) will be used. Higher scores indicate more positive adherence attitudes.

    Measured: One year

  5. ART Adherence Self-efficacy (Young People)

    The total score of the 12 item HIV medication self-efficacy scale (Erlen, Cha, Kim, Caruthers, \& Sereika, 2010) will be used. Higher scores indicated higher adherence self-efficacy.

    Measured: One year

  6. HIV Onward Disclosure Cognitions and Affect (Young People)

    The 18 item Adolescent HIV Disclosure Cognitions and Affect Scale (Evangeli, 2017) will be used to assess attitudes towards sharing one's status, normative disclosure beliefs, disclosure affect and disclosure self-efficacy.

    Measured: One year

  7. HIV Onward Disclosure (Young People)

    The 18 item Adolescent HIV Disclosure Cognitions and Affect Scale (Evangeli, 2017) will be used to assess attitudes towards sharing one's status, normative disclosure beliefs, disclosure affect and disclosure self-efficacy. The total score will be used. Higher scores indicate more pro-disclosure beliefs. An additional item assessed the young person's intention to share their status with others over the next year will be added.

    HIV disclosure events will be assessed at baseline and follow-up through recording the frequency of new disclosures in last year (first hand or second hand) and the proportion in one's social network disclosed to (Serovich, Craft, \& Reed, 2012; Serovich, Craft, \& Yoon, 2007).

    Measured: One year

  8. HIV Onward Disclosure Behaviour (Young People)

    HIV disclosure events will be assessed at baseline and follow-up through recording the frequency of new disclosures in last year (first hand or second hand) and the proportion in one's social network disclosed to (Serovich, Craft, \& Reed, 2012; Serovich, Craft, \& Yoon, 2007).

    Measured: One year

  9. HIV Communication Behaviour (Young People)

    The frequency of HIV communication will be measured.

    Measured: One year

  10. HIV Communication Beliefs (Young People)

    The Adolescent HIV Communication Belief Scale (Evangeli, in press) will be used. An additional item will assess intention to communicate about HIV.

    Measured: One year

  11. Self-esteem (Young People)

    The 10 item Rosenberg global self-esteem measure will be used (Rosenberg, 1965).

    Measured: One year

  12. HIV Stigma (Young People)

    The total score of the 10 item Stigma Scale - Revised (Wright, Naar-King, Lam, Templin, \& Frey, 2007) will be used. Higher scores indicate more HIV stigma

    Measured: One year

  13. Social Support (Young People)

    The total score of the 11 item Child and Adolescent Social Support Scale (Malecki \& Demaray, 2002) will be used. Higher scores indicate greater social support

    Measured: One year

  14. Hope(Young People)

    The total score of the 5 item Botswana Adolescent Beliefs about the Future Scale will be used. Higher scores indicate greater hope.

    Measured: One year

  15. HIV Knowledge (Caregivers)

    The HIV-KQ-18 measure (Carey \& Schroder, 2002) will be adapted for use in Botswana

    Measured: One year

  16. ART Adherence Attitudes (Caregivers)

    The 15 item antiretroviral medication attitudes scale (Viswanathan et al., 2005) will be used. The measure will be adapted for use with Batswana caregivers.

    Measured: One year

  17. HIV Stigma (Caregivers)

    The total score of the 9 item HIV Stigma Scale will be used (Kalichman et al., 2005). Higher scores indicate higher levels of HIV stigma.

    Measured: One year

  18. Viral Suppression (Young People)

    Most recent viral load in the six months before the baseline assessment and most recent viral load in the six months after the follow-up period, will be collected from participants' clinical records.

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jun 2018
  2. Study start1 Mar 2019
  3. Primary completion1 Jul 2020
  4. Study completion1 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
516 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03571555
Sponsor's protocol ID
Sentebale
Status last verified
Mar 2021
First submitted
31 May 2018
Last updated
26 Apr 2021
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Anonymised electronic data from the study will be transferred to a data repository (eg.,Figshare or RHUL Research Data Archive) at the end of the study.

Questions about this trial

What is this clinical trial studying?

An observational study of Hiv, run by Royal Holloway University at 1 site in Botswana.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Botswana. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 26 Apr 2021). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of Life/Well-being (Young People) (time frame: One year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Apr 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in